Expanded access of MK-3475 in metastatic melanoma patients with limited to no treatment options.
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Merck Sharp & Dohme
Start Date
June 1, 2014
End Date
October 8, 2015
Administered By
Duke Cancer Institute
Awarded By
Merck Sharp & Dohme
Start Date
June 1, 2014
End Date
October 8, 2015